Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Immunology
Menampilkan 21 - 40 dari 100 artikel
Evidence is growing there are changes to your immune system that may put you at risk of other infectious diseases.
A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
Coinfections with bacteria can make viral infections even deadlier. Researchers have identified a protein in immune cells that may play a role in fighting both types of pathogens.
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
COVID cases are predicted to rise as we face another variant. So a 4th shot to top up our immunity is looking more likely as we head into winter.
Because COVID-19 is a relatively new virus, researchers still aren’t sure exactly how long vaccines and prior infections provide protection.
COVID-19 has taken away so much. An immunology researcher describes the good it may leave behind.
The Novavax COVID vaccine is now available in Australia. What makes it different from the other vaccines? And why are some people waiting for it to get vaccinated?
Taking OM85 could lower the risk of developing asthma by protecting babies’ lungs from damaging infections in the early years of life.
One study suggests the virus takes an average of 36 days to clear from the body after symptoms first appear.
Variant-specific vaccines would undoubtedly increase immunity. But waves of new variants would engulf the population faster than these vaccines could ever be deployed.
There’s not enough evidence yet to support the AstraZeneca CEO’s statement. But it is theoretically plausible.
The development of COVID vaccines has already been explosive. There are more innovations on the way.
First CDC signed off on a COVID-19 vaccine for adults, then teens. Now US children ages 5 to 11 are officially eligible for shots. Here’s the science on why each group needs to be considered separately.
Protection from infection wanes over time. So boosters will offer extra protection and hopefully reduce the spread of the virus even further.
In light of mounting research showing the serious risks of contracting COVID-19 during pregnancy, the CDC is re-upping its urgency that pregnant women get their shots.
But the immune cells that vaccination spurs do last a long time.
People with HIV need to take daily medication to keep the virus at bay. A study has found that a new treatment combination could boost immunity and control virus levels even after stopping medication.
Kontributor teratas
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Program Director, Infectious Diseases and Immunology, Menzies Health Institute, Griffith University
-
Instructor of Human Immunology, Emory University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Immunology, RMIT University
-
Laboratory Head, Walter and Eliza Hall Institute
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Associate Professor of Microbiology, Immunology & Pathology, Colorado State University
-
Senior Lecturer; MD, Victoria University
-
Professor of Immunology and Associate Dean, Research and Graduate Studies, University of Guelph
-
Ph.D. Candidate in Chemical & Physical Biology, Vanderbilt Vaccine Center, Vanderbilt University
-
Ph.D. Student in Microbiology and Immunology, Vanderbilt Vaccine Center, Vanderbilt University
